The recipient, a woman from Japan, was left with severe lung damage after a COVID-19 infection she contracted last year. For more than three months, the patient was on a life support machine that operates as an artificial lung. Her lungs were significantly damaged, leaving transplant as the only option.
On April 7, the patient underwent an 11-hour transplant procedure, receiving lung tissue from two donors: her husband and son.
The surgery involved a 30-member team, led by Hiroshi Date, MD, PhD, a thoracic surgeon at Kyoto University Hospital.
The donors are in stable condition and the woman’s medical team expects she will be able to leave the hospital in about two months, CBS reports.
More articles on patient safety and outcomes:
What CDC researchers learned from studying 1,700 MIS-C issues
1 in 10 Black patients faces descrimination from healthcare staff
American College of Physicians: Shorten antibiotic duration for these 4 bacterial infections
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
